Protein signatures may one day tell brain diseases apart before symptoms
SMRTR summary
A large-scale study of proteins in blood and cerebrospinal fluid has revealed biochemical fingerprints of neurodegenerative disorders like Alzheimer's and Parkinson's. The research, involving samples from 18,645 people, could lead to improved blood tests for diagnosing brain diseases and identifying early warning signs. Key findings include a shared blood signature in APOE4 gene carriers and distinct protein patterns for different neurodegenerative diseases.
SMRTR provides this summary for quick context. The original article belongs to Science News.
Read the original article